Company / Capital Expenditures
Masimo Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$19.4M
FY2025
5-year range
$19.4M / $52.8M
FY2021-FY2025
Trend
-8.1%
vs FY2024
Sector context
#105 of 151
Health Care
What the data says
At $19M, Masimo's capital expenditures ranks #105 of 151 in the Health Care sector. Capital Expenditures has declined for 3 consecutive years, from $53M in FY2022 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of -23.2%.
Declined from $38M to $19M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -28.4%
- 5-Year CAGR
- -23.2%
- 10-Year CAGR
- -
Sector benchmark
#105 of 151 in Health CareTop 70% of 151This company $19.4M Sector average $271.7M
▼
-92.9% below sector average
Key checks
Key Insights
- Masimo's capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of -23.2%, indicating a declining trend.
- In FY2025, capital expenditures decreased 8.1% year-over-year.
- Ranks #105 out of 151 companies in the Health Care sector.
Company context
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.4M | -8.1% |
| FY2024 | $21.1M | -45.1% |
| FY2023 | $38.4M | -27.3% |
| FY2022 | $52.8M | +107.1% |
| FY2021 | $25.5M | -64.8% |
| FY2020 | $72.5M | +66.0% |
| FY2019 | $43.7M | +121.7% |
| FY2018 | $19.7M | -54.9% |
| FY2017 | $43.7M | -41.8% |
| FY2016 | $75.1M | +696.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026